Ticker
XERSCompany Name
XERIS BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 334.69M | $ 202.33M | 60.45% |
3/31/2025 | $ 315.45M | $ 182.96M | 58% |
12/31/2024 | $ 323.06M | $ 166.24M | 51.46% |
9/30/2024 | $ 321.1M | $ 152.44M | 47.47% |
6/30/2024 | $ 331.73M | $ 151.88M | 45.78% |
3/31/2024 | $ 336.62M | $ 142.06M | 42.2% |
12/31/2023 | $ 322.6M | $ 135.27M | 41.93% |
9/30/2023 | $ 327.78M | $ 125.3M | 38.23% |
6/30/2023 | $ 328.78M | $ 109.65M | 33.35% |
3/31/2023 | $ 321.36M | $ 99.69M | 31.02% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for XERIS BIOPHARMA HOLDINGS INC is calculated as follows: GP [ $ 7.6M ] / Assets [ $ 170.39M ]
(=) GPA [ 4.46% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.15% |
median | 15.35% |
std | 19.95% |